相关实验视频
Updated: Jun 22, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
与代谢功能障碍相关的脂肪性肝病的药物治疗选择:我们今天在哪里?
Tobias Puengel1,2, Frank Tacke1
1Department of Hepatology & Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 治疗正在推进,resmetirom是MASH和纤维化治疗的第一个批准的药物. 未来的疗法可能会结合方法来解决MASLD的复杂性.
科学领域:
- 肝病学和代谢疾病研究.
- 药理学和药物开发用于肝脏疾病.
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 涉及肝脏脂肪积累和心脏代谢风险.
- 进展到代谢功能障碍相关的脂肪肝炎 (MASH) 和纤维化是由持续的代谢损伤驱动的.
- 了解疾病机制已经确定了新型治疗化合物的点.
研究的目的:
- 审查目前和新兴的MASH和肝纤维化药物疗法.
- 讨论resmetirom批准和正在进行的临床试验的影响.
- 探索MASLD治疗中的挑战和未来方向.
主要方法:
- 审查最近的临床试验数据和FDA批准的药物.
- 对MASLD病原体的机制性见解的分析.
- 讨论治疗策略,包括组合疗法.
主要成果:
- 甲状腺激素受体β选择性剂Resmetirom是FDA批准的MASH和肝纤维化治疗的第一种药物.
- 单一疗法在减少肝硬化症方面表现有前途,但抗炎和抗纤维作用较弱.
- 结合疗法试验的早期结果正在调查中.
结论:
- 虽然Resmetirom的批准标志着一个重要的进步,但需要长期数据.
- 患者分层和组合疗法对于有效管理MASLD异质性至关重要.
- 对新型化合物和治疗策略的进一步研究对于改善患者的治疗结果至关重要.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
07:12Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
Published on: June 2, 2023
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...